Reports developments related to pharmaceutical industry in the U.S. as of October 2002. Approval of the U.S. Food and Drug Administration on use of the drug GHB or date-rape drug for treatment of cataplexy; Properties of the L.A.M. IPM Wound Gel; Effectiveness of Zelnorm or tegaserod maleate for treatment of women with irritable bowel syndrome.
Processing Request
No Comments.